Concepedia

S.N. Westin

SW

Statistics

Publications

4

Citations

151

H-Index

4

Active since

1982

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

S.N. Westin is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and molecular oncology.

Publications per year

1982–2019

4

Publications

4

A parallel-arm phase I trial of the humanised anti-IGF-1R antibody dalotuzumab in combination with the AKT inhibitor MK-2206, the mTOR inhibitor ridaforolimus, or the NOTCH inhibitor MK-0752, in patients with advanced solid tumours

Irene Braña, Raanan Berger, Talia Golan et al. · British Journal of Cancer · 2014 · 89 citations · Full text

, , +17

Metabolic Control in 131 Juvenile-onset Diabetic Patients as Measured by HbA1c: Relation to Age, Duration, C-Peptide, Insulin Dose, and One or Two Insulin Injections

G Dahlquist, Lisa Blom, Per Bolme et al. · Diabetes Care · 1982 · 31 citations

, , +16

Phase I expansion of olaparib (PARP inhibitor) and AZD5363 (AKT inhibitor) in recurrent ovarian, endometrial and triple negative breast cancer

S.N. Westin, Jennifer K. Litton, Rhys Williams et al. · Annals of Oncology · 2017 · 16 citations · Full text

, , +17

IMRT Improves Late Toxicity Compared to Conventional RT: An Update on NRG Oncology-RTOG 1203

Anamaria R. Yeung, S. Pugh, Ann H. Klopp et al. · International Journal of Radiation Oncology*Biology*Physics · 2019 · 15 citations

, , +10

1–4 of 4